DuPont de Nemours, Inc. (DD)
DuPont: Macro Pressures Persist, Q3 Guidance Could Be Weak (Rating Downgrade)
DuPont remains undervalued, but I move from Strong Buy to Buy due to Q3 guidance concerns and currency headwinds. Q2 is expected to deliver a small beat, driven by strong healthcare and aerospace, though construction market softness persists in Diversified Industrials. DD's recent $275M accelerated share repurchase signals management's conviction in undervaluation, supported by robust EPS growth and margin expansion.
DuPont Achieves Renewable Power Milestone in US Healthcare Sites
DuPont's U.S. healthcare manufacturing sites now run on renewable electricity, advancing climate goals and lowering emissions.
DuPont MemCor MBR Selected for Riverstone Upgrade in Australia
DD's MemCor MBR tech was chosen for Sydney's Riverstone WRRF upgrade, boosting wastewater capacity to support growth and protect waterways.
DuPont Plans Reverse Stock Split, Backs Guidance
The materials and chemicals company said the reverse split was approved by both shareholders and the board of directors.
Congress and retailers want to rebuild national parks. Tolls on federal roads might pay for it
Congress wants to fund a rebuild of the United States' aging national parks before the country's 250th birthday. Paying for it is becoming a problem.
DD Q1 Earnings Beat on Productivity Gains, Sales Rise Y/Y
DuPont beats Q1 estimates as productivity gains lift profits and sales rise, with stronger healthcare and aerospace demand driving growth.
DuPont rallies after strong results—more upside ahead?
Shares of DuPont rose sharply on Tuesday after the industrial materials maker reported first-quarter results that exceeded analyst expectations and raised its full-year financial outlook, signaling resilience despite rising input costs linked to geopolitical tensions. The stock climbed about 8.9% to around $49.46, reaching its highest level since March.
DuPont de Nemours, Inc. (DD) Q1 2026 Earnings Call Transcript
DuPont de Nemours, Inc. (DD) Q1 2026 Earnings Call Transcript
Compared to Estimates, DuPont de Nemours (DD) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for DuPont de Nemours (DD) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
DuPont Lifts Outlook, Plans $275 Million Buyback
DuPont de Nemours lifted its outlook and plans to buy back $275 million of stock after swinging to a profit in the first quarter.
Cwm LLC Has $4.43 Million Position in DuPont de Nemours, Inc. $DD
Cwm LLC grew its position in DuPont de Nemours, Inc. (NYSE: DD) by 15.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 110,097 shares of the basic materials company's stock after acquiring an additional 14,546 shares during
DuPont: Considerably Undervalued
DuPont trades at a substantial discount to peers despite similar growth and margin profiles, creating a compelling long opportunity. Post-Qnity spin-off, DD is a streamlined, high-margin business with strong free cash flow and a clear focus on Healthcare & Water Technologies. Management's conservative guidance suggests potential for consistent earnings beats, with full-year adj. EPS expected around $2.40 versus street at $2.35.
